Seelos Therapeutics Stock Price, News & Analysis
Company Description
Seelos Therapeutics (OTC: SEEL) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $527.6K, ranking #7,068 among all listed U.S. companies by market cap.
SEEL stock has declined 99.9% over the past year. Shares last traded at $0.3900.
This page provides a comprehensive overview of SEEL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Seelos Therapeutics (SEEL) stock last traded at $0.3900. Over the past 12 months, the stock has lost 99.9%. At a market capitalization of $527.6K, SEEL is classified as a micro-cap stock with approximately 436.0K shares outstanding.
Latest News
Seelos Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include stock split, private placement, offering, clinical trial, fda approval. View all SEEL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SEEL Company Profile & Sector Positioning
Seelos Therapeutics (SEEL) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the OTC.